Biotechnology Stocks I Performance Guide: Neumora Therapeutics, Inc. (NMRA)
NMRA has no dividends.
Table and Chart of NMRA Performance
See what a $1,000 investment in NMRA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NMRA Returns | |
|---|---|
| Start Date | Oct-31-2023 |
| Start Price | $10.92 |
| End Date | Oct-11-2024 |
| End Price | $15.51 |
| # Prices | 13 |
| Min Date | Apr-30-2024 |
| Min Price | $9.09 |
| Max Date | Feb-29-2024 |
| Max Price | $17.63 |
| Total Return | 42.03% |
| Annualized Return | 38.25% |
| Current Value of $1,000 Purchase | $1,420 |
| Number Returns | 78 |
| Average Return | 1.72% |
| Number Profitable Returns | 39 |
| Percent Profitable Returns | 50.00% |
| Number Unprofitable Returns | 39 |
| Percent Unprofitable Returns | 50.00% |
| Profitable to Unprofitable Returns Ratio | 1.00 |
| NMRA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -4.648 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -230203008 |
| PE to Growth Ratio | None |
| Price to Book | - |
| PRICE DATA | |
| 52 Week High | $None |
| 52 Week Low | $21 |
| Analyst Target Price | $0 |
| 50-Day Moving Average | $8.33 |
| 200-Day Moving Average | $12.28 |
| FINANCIAL DATA | |
| Revenue per Share | $-1.72 |
| Revenue | $-1 |
| Profit Margin | 0% |
| Return on Equity | -37.8% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NMRA Compare Returns with S&P 500
NMRA Trendline Chart
NMRA Moving Average Chart
NMRA Stock Return Map - See Patterns of Gains and Losses
NMRA Stock Returns/Purchase Dates